These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 17683910

  • 21. Tetrabenazine for tardive tremor in elderly adults: a prospective follow-up study.
    Kertesz DP, Swartz MV, Tadger S, Plopski I, Barak Y.
    Clin Neuropharmacol; 2015; 38(1):23-5. PubMed ID: 25580924
    [Abstract] [Full Text] [Related]

  • 22. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease.
    Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Eberly S, Walker F, Factor S, Hunt V, Shinaman A, Jankovic J.
    Clin Neuropharmacol; 2008; 31(3):127-33. PubMed ID: 18520979
    [Abstract] [Full Text] [Related]

  • 23. Successful use of tetrabenazine in a patient with intractable hiccups after stroke.
    Naro A, Bramanti P, Calabrò RS.
    Pharmacotherapy; 2014 Dec; 34(12):e345-8. PubMed ID: 25471210
    [Abstract] [Full Text] [Related]

  • 24. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
    Chen JJ, Ondo WG, Dashtipour K, Swope DM.
    Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259
    [Abstract] [Full Text] [Related]

  • 25. How best to address these common movement disorders.
    Yaman A, Akdeniz M, Yaman H.
    J Fam Pract; 2011 Dec; 60(12):721-5. PubMed ID: 22163354
    [No Abstract] [Full Text] [Related]

  • 26. Parkinson's disease and other movement disorders.
    Chen JJ.
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):293. PubMed ID: 20869619
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Impact of tetrabenazine on gait and functional mobility in individuals with Huntington's disease.
    Kegelmeyer DA, Kloos AD, Fritz NE, Fiumedora MM, White SE, Kostyk SK.
    J Neurol Sci; 2014 Dec 15; 347(1-2):219-23. PubMed ID: 25456459
    [Abstract] [Full Text] [Related]

  • 32. Tetrabenazine, depression and suicide: good news.
    Margolis RL.
    J Huntingtons Dis; 2014 Dec 15; 3(2):137-8. PubMed ID: 25062856
    [No Abstract] [Full Text] [Related]

  • 33. Role of tetrabenazine for Huntington's disease-associated chorea.
    Poon LH, Kang GA, Lee AJ.
    Ann Pharmacother; 2010 Jun 15; 44(6):1080-9. PubMed ID: 20442355
    [Abstract] [Full Text] [Related]

  • 34. The pharmacokinetics of tetrabenazine and its hydroxy metabolite in patients treated for involuntary movement disorders.
    Roberts MS, McLean S, Millingen KS, Galloway HM.
    Eur J Clin Pharmacol; 1986 Jun 15; 29(6):703-8. PubMed ID: 3709613
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.